Publications by authors named "Halil Degertekin"

Claim this Profile
A
A New Risk-Scoring System for Colorectal Cancer and Polyp Screening by Turkish Colorectal Cancer and Polyp Study Group.
Levent Erdem, Erdem Akbal, Erdem Koçak, Dilek Tucer, Enver Üçbilek

Turk J Gastroenterol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
Gülbanu Erkan, Irmak Sayın, Fatma Betül Polat, Ahmet Çorakçı, Gökçe Kaan Ataç

Turk J Gastroenterol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thorax as an extraintestinal target for inflammatory bowel disease.
Evrim Eylem Akpınar, Meral Gülhan, Halil Değertekin, Ömür Ataoğlu

Tuberk Toraks· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginterferon plus adefovir versus either drug alone for hepatitis delta.
Heiner Wedemeyer, Cihan Yurdaydìn, George N Dalekos, Andreas Erhardt, Yilmaz Çakaloğlu

N Engl J Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis.
Kalliopi Zachou, Cihan Yurdaydin, Uta Drebber, George N Dalekos, Andreas Erhardt, Halil Degertekin

Liver Int· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis.
Halil Değertekin, Kendal Yalçin, Mustafa Yakut, Cihan Yurdaydin

Liver Int· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies.
Halil Değertekin, Kendal Yalçin, Mustafa Yakut

Turk J Gastroenterol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late failure of combined recombinant hepatitis B vaccine and lamivudine in treatment of a patient with chronic hepatitis B.
Kendal Yalcin, Halil Degertekin, Mithat Bozdayi

South Med J· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Kendal Yalçin, Halil Değertekin, Omer Faruk Kokoğlu, Celal Ayaz

Turk J Gastroenterol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
Kendal Yalcin, Halil Degertekin, Fetin Yildiz, Nihal Kilinc

J Gastroenterol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lack of effect of therapeutic vaccination with a pre-S2/S HBV vaccine in the immune tolerant phase of chronic HBV infection.
Kendal Yalcin, Ramazan Danis, Halil Degertekin, M Nail Alp, Selahattin Tekes

J Clin Gastroenterol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.
Kendal Yalçin, Halil Değertekin, M Nail Alp, Selahattin Tekeş, Omer Satici

Turk J Gastroenterol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clear cell carcinoma of the liver: a case report.
Nihal Kilinç, Kendal Yalçin, Halil Değertekin, Mehmet Ozaydin

Turk J Gastroenterol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of HBeAg seroconversion in acute exacerbation of liver disease with termination of hepatitis B and D virus infection in a chronic hepatitis D patient during alpha-interferon therapy.
Kendal Yalcin, Halil Degertekin, Cihan Yurdaydin, Mithat Bozdayi, Hakan Bozkaya

Eur J Gastroenterol Hepatol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 12-month courses of interferon-alpha-2b-lamivudine combination therapy and interferon-alpha-2b monotherapy among patients with untreated chronic hepatitis B.
Kendal Yalcin, Halil Degertekin, Fetin Yildiz, Yusuf Celik

Clin Infect Dis· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal mesothelioma associated with exposure to asbestos in southeastern Turkey.
Halil Değertekin, Kendal Yalçin, Recep Işik

J Clin Gastroenterol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Markers of disease activity in chronic hepatitis B virus infection.
Kendal Yalcin, Halil Degertekin, Fetin Yildiz, Yusuf Celik

Clin Invest Med· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis